TooNiceStocks.com - Sign up for weekly Technical and Equity Research Reports covering all equity sectors. We have a proven track record, please come visit and see for yourself.
New York, NY -- (SBWIRE) -- 03/19/2013 -- Affymax, Inc. (NASDAQ:AFFY) The biotechnology company said Monday it will reduce its work force by 75% and may sell itself. Both actions are linked to an investigation of Affymax’s antianemia drug Omontys, which it recalled after it led to fatal reactions in some first-time users. AFFY is on a bearish fall, trading at $1.22 (-58.22%) during pre-market, with over 4 million shares that have exchanged hands, will AFFY continue to fall or bounce back like before? Stick around.
NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) NPS Pharmaceuticals Inc. is trading at an intraday of $10.51 (+16.26%) with over 5.4 million shares exchanged, will NPSP continue to push towards the end of day? Stick around.
Electronic Arts Inc. (NASDAQ:EA) Electronic Arts Inc. is on a bearish sell off, trading at an intraday of $17.19 (-8.12%) with over 12.9 million shares traded, will EA bounce back on these oversold conditions? Stick around.
Glu Mobile Inc. (NASDAQ:GLUU) Glu Mobile Inc. sold off on early trading, trading at an intraday of $3.448 (-4.49%) with over 4.4 million shares that have exchanged hands, will GLUU re-gain bullish momentum? Stay tuned.
ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) ZIOPHARM Oncology Inc. sold off this morning, trading at an intraday of $5.38 (-5.78%) with over 2 million shares exchanged, will ZIOP continue to fall? Stick around.
View Full NASDAQ Report: http://toonicestocks.com/news/2948-nasdaq-bleed-bloody-market-affy-npsp-ea-gluu-ziop
Sign up now for free weekly technical and research reports. Read our daily popular speaking research blogs. We work hard in researching companies in all exchanges. Please add us on Twitter http://www.twitter.com/toonicestock s or like us on
Facebook http://www.facebook.com/pages/TooNiceStocks/243228112357605?ref=ts Real Research for Real Investors.
None of the companies mentioned by TooNiceStocks.com in our daily market research blogs, constitutes a recommendation for any investor to purchase or sell any particular security or that any security is suitable for any investor. TooNiceStocks.com in no way has been compensated for advertising, marketing or profiling any of these companies, rather we have initiated our own independent research. The data stated in our research blog is derived from publicly disseminated information. Examples presented on TooNiceStocks.com website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments as these are our own opinions. Please note well that TooNiceStocks.com employees are not Registered as an Investment Advisor in any jurisdiction whatsoever.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-321-1250 (International)